Prasansha Singla M.Sc, Department of Forensic Science, Amity University, Greater Noida 201301, Uttar Pradesh, India
Address for correspondence: Prasansha Singla, M.Sc, Department of Forensic Science, Amity University, Greater Noida 201301, Uttar Pradesh, India E-mail: prasansha0828@gmail.com
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Journal of Global Medical Education and Research
5(1):p 9-17, January-June 2022. | DOI: NA
How Cite This Article:
Prasansha Singla/Study on Blood Group and their Forensic Aspects/Journal of Global Medical Education and Research/2022;5 (1):9-17
Timeline
Received : May 25, 2022
Accepted : June 14, 2022
Published : June 30, 2022
Abstract
Prior to the widespread adoption of DNA typing, the blood group system was an important component in forensic serological examination of blood and body fluids. Blood grouping is one of the most important aspects in the term of forensic investigation because the blood plays a very crucial role when it comes to individualization and identification. It is one of the most reliable source and one of the most common evidence which found on the crime scene. The condition in which the blood is present or encountered on the crime scene may vary. It helps in the identification of the person with respect to its height in the case of the spattering of the blood or blood spatter analysis. It also link suspects to the crime scene and also narrows down the investigation process.
References
1. Owen R. Karl Landsteiner and the first human marker locus. Genetics. 2000;155:995–8.
2. Lögdberg L, Reid ME, Lamont RE, Zelinski T. Human blood group genes 2004: Chromosomal locations and cloning strategies. Transfus Med Rev. 2005;19:45–57.
3. Lögdberg L, Reid ME, Zelinski T. Human blood group genes 2010: Chromosomal locations and cloning strategies revisited. Transfus Med Rev. 2011;25:36–46.
4. Westhoff CM. The Rh blood group system in review: A new face for the next decade. Transfusion. 2004;44:1663–73.
5. Agarwal N, Thapliyal RM, Chatterjee K. Blood group phenotype frequencies in blood donors from a tertiary care hospital in north India. Blood Res. 2013;48:51–4.
6. Anstee DJ. The functional importance of blood group-active molecules in human red blood cells. Vox Sang. 2011;100:140–9.
7. Daniels G, Reid ME. Blood groups: The past 50 years. Transfusion. 2010;50:281–9.
8. Denomme GA. The structure and function of the molecules that carry human red blood cell and platelet antigens. Transfus Med Rev. 2004;18:203–31.
9. Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol. 2000;20:3097–101.
10. Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol. 1991;146:3502–7.
11. Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med. 1988;167:1993–8.
12. Zhang H, Mooney CJ, Reilly MP. ABO Blood Groups and Cardiovascular Diseases. Int J Vasc Med 2012. 2012:641917.
13. Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost. 2009;7:263–9.
14. Tufano A, Coppola A, Nardo A, Bonfanti C, Crestani S, Cerbone AM, et al. Non-O blood group as a risk factor for cerebral vein thrombosis. Thromb Haemost. 2013;110:197–9.
15. Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T, et al. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: A population-based nested case-control study. Thromb Res. 2009;124:167–73.
16. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, et al. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012;131:461–8.
17. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer. 2011;128:482– 6.
18. Anstee DJ. The relationship between blood groups and disease. Blood. 2010;115:4635–43.
19. Miller RD. Transfusion therapy. In: Miller RD, Ericksson LI, Fleischer LA, Weiner-Kronish JP, Young LA, editors. Miller’s Anesthesia. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. pp. 1739–66.
20. Ghirardo SF, Mohan I, Gomensoro A, Chorost MI. Routine preoperative typing and screening: A safeguard or a misuse of resources. JSLS. 2010;14:395–8.
21. Onotai L, Lilly-Tariah OD. Adenoid and tonsil surgeries in children: How relevant is pre-operative blood grouping and cross-matching? Afr J Paediatr Surg. 2013;10:231–4.
22. Goldstein J, Siviglia G, Hurst R, Lenny L, Reich L. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science. 1982;215:168–70.
23. Goldstein J. Conversion of ABO blood groups. Transfus Med Rev. 1989;3:206–12.
24. Liu QP, Sulzenbacher G, Yuan H, Bennett EP, Pietz G, Saunders K, et al. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol. 2007;25:454–64.
25. Kobayashi T, Liu D, Ogawa H, Miwa Y, Nagasaka T, Maruyama S, et al. Alternative strategy for overcoming ABO incompatibility. Transplantation. 2007;83:1284–6.
26. Hashemi-Najafabadi S, Vasheghani-Farahani E, Shojaosadati SA, Rasaee MJ, Armstrong JK, Moin M, et al. A method to optimize PEG-coating of red blood cells. Bioconjug Chem. 2006;17:1288–93.
27. Ness P M , Shirey R S , Thoman S K , Buck S A . The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, longterm serologic findings, and clinical significance. Transfusion. 1990;30:688–93.
28. Morgan P, Wheeler C B, Bossom E L. Delayed transfusion reaction attributed to anti-Jkb. Transfusion. 1967;7:307–8.
29. Holland P V, Wallerstein R O . Delayed hemolytic transfusion reaction with acute renal failure. JAMA. 1968;204:1007–8.
30. Geifman-Holtzman O , Wojtowycz M , Kosmas E , Artal R . Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol. 1997;89:272–5.
31. Matson G A , Swanson J , Tobin J D . Severe hemolytic disease of the newborn caused by anti-Jka. Vox Sang. 1959;4:144–7.
32. Olives B , Merriman M , Bailly P , Barnett A , Todd J , Cartron J P , Merriman T . The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility. Hum Mol Genet. 1997;Jul;6(7):1017–20.
33. Irshaid N M , Thuresson B , Olsson M L . Genomic typing of the Kidd blood group locus by a singletube allele-specific primer PCR technique. Br J Haematol. 1998 ;Sep;102(4):1010–4.
34. Araujo F , Pereira C , Monteiro F , Henriques I, Meireles E , Lacerda P , Aleixo A , Rodrigues M J , Cunha-Ribeiro R M , Araujo F . Blood group antigen profile predicted by molecular biology-use of real-time polymerase chain reaction to genotype important KEL, JK,RHD, and RHCE alleles. Immunohematol. 2002;18(3):59–64.
35. Irshaid N M , Eicher N I , Hustinx H , Poole J , Olsson M L . Novel alleles at the JK blood group locus explain the absence of the erythrocyte urea transporter in European families. Br J Haematol. 2002;116:445–53
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Prasansha Singla/Study on Blood Group and their Forensic Aspects/Journal of Global Medical Education and Research/2022;5 (1):9-17
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.